Assenagon Asset Management’s Standard BioTools LAB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-417,917
| Closed | -$740K | – | 1378 |
|
|
2024
Q2 | $740K | Sell |
417,917
-160,522
| -28% | -$284K | ﹤0.01% | 1147 |
|
|
2024
Q1 | $1.57M | Buy |
578,439
+512,937
| +783% | +$1.39M | ﹤0.01% | 934 |
|
|
2023
Q4 | $145K | Buy |
+65,502
| New | +$145K | ﹤0.01% | 1331 |
|
|
2021
Q2 | – | Sell |
-674,525
| Closed | -$3.05M | – | 1269 |
|
|
2021
Q1 | $3.05M | Buy |
674,525
+37,772
| +6% | +$171K | 0.01% | 582 |
|
|
2020
Q4 | $3.82M | Sell |
636,753
-477,477
| -43% | -$2.87M | 0.02% | 376 |
|
|
2020
Q3 | $8.28M | Sell |
1,114,230
-30,998
| -3% | -$230K | 0.05% | 194 |
|
|
2020
Q2 | $4.59M | Buy |
1,145,228
+669,763
| +141% | +$2.69M | 0.03% | 323 |
|
|
2020
Q1 | $1.21M | Buy |
+475,465
| New | +$1.21M | 0.01% | 450 |
|
|
2019
Q4 | – | Sell |
-208,730
| Closed | -$966K | – | 814 |
|
|
2019
Q3 | $966K | Buy |
208,730
+103,330
| +98% | +$478K | 0.01% | 525 |
|
|
2019
Q2 | $1.3M | Buy |
+105,400
| New | +$1.3M | 0.01% | 613 |
|